Inspire Medical Systems (STU:2DR) Moat Score: 7/10 (As of Jul. 04, 2026)


STU:2DR Inspire Medical Systems Inc STU:2DR
56 GF Score
Price €40.80
GF Value €188.24
Valuation Possible Value Trap
! 7 Warning Signs
View Full Analysis

What is Inspire Medical Systems Moat Score?

Inspire Medical Systems STU:2DR -0.49% 56 Moat Score is 7 as of Jul. 04, 2026. GuruFocus rates STU:2DR with a GF Score™ of 56/100 and a GF Value™ of €188.24 (Possible Value Trap). The stock has 7 warning signs investors should review. Among 845 Medical Devices & Instruments companies, Inspire Medical Systems ranks better than 98.93% on this metric.

Inspire Medical Systems has the Moat Score of 7, which implies that the company might have Wide Moat - Entry-level wide moat, clearly possessing durable advantages.

Inspire Medical Systems has Wide Moat: Inspire Medical Systems Inc has a wide moat with strong intellectual property, significant customer switching costs, and regulatory barriers in the medical device industry. Its innovative products and strong brand provide durable competitive advantages.

Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more.

The company's Moat Score is based on these criteria:

1. Market leadership and sustainable market share
2. Network effects and significant customer switching costs
3. Valuable intellectual property and patents
4. Strong brand strength and deep customer loyalty
5. Durable cost advantages (e.g., economies of scale, proprietary technology)
6. Significant regulatory barriers and exclusive licenses
7. Superior distribution network
8. Strong and sustainable pricing power
9. Consistent and impactful innovation and R&D capabilities

Based on the research, GuruFocus believes Inspire Medical Systems might have Wide Moat - Entry-level wide moat, clearly possessing durable advantages.

Inspire Medical Systems  (STU:2DR) Moat Score Explanation

The Moat Score ranges from 0 to 10, with 10 as the highest. GuruFocus divided Moat Score into following 8 categories:

Moat Score Moat Level
10Wide Moat - Exceptionally dominant and durable wide moat
8 - 9Wide Moat - Clear and robust wide moat
7Wide Moat - Entry-level wide moat, clearly possessing durable advantages
6Narrow Moat - Strong narrow moat, clearly distinguishable but not wide
5Narrow Moat - Solid narrow moat
4Narrow Moat - Discernible but modest moat
1 - 3No Moat - Very weak/transient advantages
0No Moat - No discernible moat

Inspire Medical Systems Moat Score Related Terms

STU:2DR vs ENOV, PRCT, AHCO: Moat Score Comparison

For the Medical Devices subindustry, Inspire Medical Systems's Moat Score, along with its competitors' market caps and Moat Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Inspire Medical Systems Moat Score vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Inspire Medical Systems's Moat Score distribution charts can be found below:

* The bar in red indicates where Inspire Medical Systems's Moat Score falls into.


STU:2DR
56GF Score
Inspire Medical Systems Inc STU:2DR
Moat Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about Moat Score →
What does a Moat Score of 7 mean?
Inspire Medical Systems (STU:2DR) has a Moat Score of 7 as of Jul. 04, 2026. Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more. According to the industry distribution chart, Inspire Medical Systems ranks #9 out of 845 companies in the Medical Devices & Instruments industry, placing it in the top 1.1%.
Is Inspire Medical Systems' Moat Score too high?
Inspire Medical Systems' current Moat Score is 7. Based on the distribution chart, Inspire Medical Systems ranks #9 out of 845 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Inspire Medical Systems has a GF Score™ of 56/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Inspire Medical Systems' Moat Score compare to ENOV and PRCT?
According to the Medical Devices & Instruments industry distribution chart, Inspire Medical Systems ranks #9 out of 845 companies for Moat Score. This places Inspire Medical Systems in the top 1% of its industry — outperforming the majority of peers. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Moat Score for a Medical Devices & Instruments company?
A good Moat Score depends on the Medical Devices & Instruments industry context. However, Moat Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Moat Score mean?
A high Moat Score can signal that a stock is expensive relative to its fundamentals. Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more. Inspire Medical Systems's current Moat Score is 7. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Inspire Medical Systems stock overvalued right now?
Based on GuruFocus' analysis, Inspire Medical Systems (STU:2DR) is currently considered Possible Value Trap. The stock's GF Value™ is €188.24, compared to a current price of €40.80 — trading 78.3% below its estimated fair value. The current Moat Score is 7. Inspire Medical Systems' overall GF Score™ is 56/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Moat Score calculated?
Moat Score is calculated from a company's financial statements. For Inspire Medical Systems (STU:2DR), the current Moat Score is 7 as of Jul. 04, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Inspire Medical Systems (STU:2DR) Overvalued in 2026?

Based on GuruFocus' analysis, Inspire Medical Systems stock appears to be undervalued. The current stock price of €40.80 is trading 78.3% below its estimated GF Value™ of €188.24. GuruFocus considers Inspire Medical Systems to be Possible Value Trap.

Key valuation signals for STU:2DR:

  • Moat Score: 7
  • GF Value™: €188.24 vs. price of €40.80 (78.3% below fair value)
  • GF Score™: 56/100 with 7 warning signs

No single metric tells the full story. See the STU:2DR stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Inspire Medical Systems Business Description

Other Exchanges INSP:USA
Address 5500 Wayzata Boulevard, Suite 1600, Golden Valley, MN, USA, 55416
Inspire Medical Systems Inc operates as a medical technology company. It focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA). It offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea. The firm has operating footprints in the United States and All other countries wherein, it generates a majority of its revenue from the United States. Its segment revenues are derived from the sales of its product, the Inspire system, to hospitals and ambulatory surgery centers in the U.S. and in selected countries in Europe and the Asia Pacific region.
56GF Score

Get the complete analysis for STU:2DR

Moat Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€40.80
Price
€188.24
GF Value